Aviation Medication Transparency Act of 2025
Key claim: HR2592 would require the FAA to compile and publicly publish an annually updated list of medications safe for pilots and air traffic controllers to use while holding medical certification.
Abstract
(HR2592 · 119th Congress) Aviation Medication Transparency Act of 2025 This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification. Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications. Latest action (2025-04-02): Referred to the House Committee on Transportation and Infrastructure.
Why this matters
Pilot and controller medication policy directly affects aviation safety by shaping which airmen can fly while treating common conditions; opaque guidance is widely cited as a driver of non-disclosure and self-medication. A published, regularly updated list would give airmen and aviation medical examiners a single authoritative reference, potentially reducing certification uncertainty without altering the underlying safety standard.